TMDX
TransMedics Group, Inc. · Healthcare · Market cap $2.8B
Insiders sold $613K net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Sep 14, 2026
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Sep 14, 2026
Weill David
TransMedics Group, Inc. (TMDX) has 25 SEC Form 4 filings (35 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Sep 14, 2026.
Inside the rolling window, 8 insiders at TransMedics Group, Inc. reported 2 open-market purchases totaling $1.1M and 11 open-market sales totaling $4.9M. The most active filer is Director Weill David with 3 filings. Insiders have net sold $613K over the trailing 6 months. The most recent open-market filing is a purchase of 1,336 shares by Director Weill David, dated Sep 11, 2026, worth $109K.
- Industry:Medical - Devices
- CEO:Waleed H. Hassanein
- Employees:898
- HQ:Andover, MA, US
- IPO:2019-05-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Weill DavidFirst in 6 months | Director | Purchase | 1,336 | $109K | Sep 14 | — | SEC ↗ |
Gunderson Thomas J.First filing | Director | Sale | 9,624 | $722K | Jun 17 | +12.2% | SEC ↗ |
Weill DavidFirst in 3 months | Director | Sale | 3,571 | $524K | Mar 6 | -36.6% | SEC ↗ |
Lovell StephanieFirst filing | Director | Sale | 1,193 | $178K | Mar 6 | -36.6% | SEC ↗ |
| Chief Financial Officer | Sale | 375 | $52K | Mar 4 | -44.3% | SEC ↗ | |
| Chief Financial Officer | Sale | 7,236 | $1.1M | Mar 4 | -44.3% | SEC ↗ | |
Corcoran NicholasFirst filing | See remarks | Sale | 2,966 | $413K | Mar 4 | -44.3% | SEC ↗ |
Ranganath Anil P.First in 3 months | See remarks | Sale | 864 | $120K | Mar 4 | -44.3% | SEC ↗ |
Weill DavidFirst filing | Director | Sale | 5,000 | $693K | Dec 5 | -39.8% | SEC ↗ |
Hernandez GerardoFirst filing | Chief Financial Officer | Sale | 920 | $128K | Dec 5 | — | SEC ↗ |
Ranganath Anil P.First filing | See remarks | Sale | 3,000 | $436K | Nov 26 | — | SEC ↗ |
Hassanein Waleed HFirst filing | President & CEO | Purchase | 8,775 | $1.0M | Nov 18 | — | SEC ↗ |
Basile Edward MFirst filing | Director | Sale | 4,142 | $540K | Oct 31 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does TMDX have?
TransMedics Group, Inc. (TMDX) has 25 SEC Form 4 filings (35 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Sep 14, 2026.
When was the most recent SEC Form 4 filing for TMDX?
The most recent Form 4 filing for TMDX on Tracefour is dated Sep 14, 2026.
Who is the most active insider at TMDX?
The most active SEC Form 4 filer at TMDX in the rolling window is Director Weill David, with 3 filings.
What is the net insider flow at TMDX over the last 6 months?
Over the trailing 180 days, insiders at TMDX have net sold $613K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TMDX in the current window?
Inside the rolling window, insiders at TMDX bought $1.1M and sold $4.9M based on SEC Form 4 filings.
Can I get alerts for TMDX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TransMedics Group, Inc. (TMDX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
TransMedics Group, Inc. is in the Healthcare sector.